DMD and neuromuscular disease caused by qualitative or quantitative defects of dystrophin: These data thus confirm the relevance of ASD in dystrophinopathies and the need to systematically analyze dystrophin variants in ASD cohorts as this approach can reveal relevant variants with a higher impact on the CNS than on muscle, as we will discuss below.